NL-OMON22097招募中不适用
Reexamining the impact of dual antiplatelet medication as predictive factor for allogeneic blood transfusion during validation of the TRACK transfusion prediction model in a Dutch adult cardiac surgery population
Department of Cardiac Surgery and Department of Anesthesia Amsterdam UMC0 个研究点目标入组 3,500 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Patients > 18 years
- •Patients receiving on-pump cardiac surgery.
- •Patients receiving off-pump cardiac surgery.
排除标准
- •A potential patient who meets any of the following criteria will be excluded from participation in the data collection:
- •Cardiac surgery for congenital disorders
研究者
相似试验
已完成
不适用
Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery DiseaseArteriosclerosis obliteransJPRN-UMIN000034867Hyogo College of Medicine151
招募中
不适用
Safety and efficacy of 1-month dual antiplatelet therapy in high bleeding and ischemic risk elderly patients with coronary artery disease after implantation of zotarolimus-eluting coronary stent system (Resolute Onyx™ , Medtronic, Minneapolis, MN); A multicenter, prospective, observational studyFactors influencing health status and contact with health servicesKCT0008377Pusan National University Yangsan Hospital500
已完成
不适用
oborI dual antiplatelet therapy as aPPropriate duratiON (NIPPON)Coronary Artery DiseaseJPRN-UMIN000006698PO Associations for Establishment of Evidence in Interventions4,598
已完成
2 期
Dual anti-platelet therapy in coronary artery bypass graft surgerycoronary artery bypass graft.Presence of coronary angioplasty implant and graftIRCT20171113037434N1Sanofi-Aventis Pharmaceutical Company216
进行中（未招募）
1 期
Assessment of Dual antiplatelet therapy versus Rivaroxaban In atrial Fibrillation patients Treated with left atrial appendage closure: The randomized ADRIFT Study - ADRIFTMedDRA version: 19.1 Level: PT Classification code 10003658 Term: Atrial fibrillation System Organ Class: 10007541 - Cardiac disordersEUCTR2017-001567-20-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)90